LCN2 and collagenous colitis: Mucosal and fecal NGAL has also been evaluated in the context of collagenous colitis, and it has been shown that NGAL mRNA is upregulated in active disease and reduced in corticosteroid-induced clinical remissions, which is reflected in fecal NGAL concentrations [12].